Genome-wide CRISPR/Cas9 screening for drug resistance in tumors.
Zhang Z, Wang H, Yan Q, Cui J, Chen Y, Ruan S, Yang J, Wu Z, Han M, Huang S, Zhou Q, Zhang C, Hou B.
Zhang Z, et al. Among authors: zhou q.
Front Pharmacol. 2023 Nov 21;14:1284610. doi: 10.3389/fphar.2023.1284610. eCollection 2023.
Front Pharmacol. 2023.
PMID: 38084101
Free PMC article.
Review.